ATXA Therapeutics is looking forward to working with the IBI team. https://www.independent.ie/business/irish/ibi-to-raise-500m-for-earlys...

ATXA Therapeutics is excited to be in #London for #LSXWorld Congress 2019. #PAH #SMEs @EU_H2020 @H2020SME @Entirl @NovaUCD

https://bizplus.ie/therese-kinsellas-skin-in-the-game/

Happy Science Week! ATXA Therapeutics Limited is delighted to be listed among the 10 Irish science-based startups to watch. New hope for...

DUBLIN, IRELAND – November 13, 2018 – ATXA Therapeutics Ltd CEO, Dr. Ivan Coulter will today attend the Biotech and Money Inv€$tival...

DUBLIN, IRELAND – October 26, 2018 – ATXA Therapeutics (“ATXA”), a pharmaceutical company focused on the discovery and development of new...

DUBLIN, IRELAND – September 10, 2018 – From 10-11 September 2018, the European Innovation Council (EIC) will host more than 600 top SMEs,...

DUBLIN, IRELAND – May 15, 2018 – ATXA Therapeutics Limited, an Irish company developing novel therapeutic drugs for the treatment of...

DUBLIN, IRELAND – May 10, 2018 – Founder & Chief Scientific Officer of ATXA Therapeutics, Prof. Therese Kinsella, attended a reception...

DUBLIN, IRELAND – April 3, 2018 – ATXA Therapeutics Limited Founder and Chief Scientific Officer, Prof. Therese Kinsella, PhD, MRIA, will...